Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 3368

2.

Effect of alendronate or 8-prenylnaringenin applied as a single therapy or in combination with vibration on muscle structure and bone healing in ovariectomized rats.

Komrakova M, Rechholtz C, Pohlmann N, Lehmann W, Schilling AF, Wigger R, Sehmisch S, Hoffmann DB.

Bone Rep. 2019 Aug 27;11:100224. doi: 10.1016/j.bonr.2019.100224. eCollection 2019 Dec.

3.

Unexpected rapid increase in bone mineral density by bisphosphonate therapy after multiple spinal fractures: a case report.

Koiwai H, Kamimura M, Takahashi J, Nakamura Y, Kato H.

J Med Case Rep. 2019 Sep 13;13(1):288. doi: 10.1186/s13256-019-2219-0.

4.

Efficacy and Safety of First- and Second-Line Drugs to Prevent Glucocorticoid-Induced Fractures: A Network Meta-Analysis.

Ding L, Hu J, Wang D, Liu Q, Mo Y, Tan X, Wen F.

J Clin Endocrinol Metab. 2019 Sep 12. pii: dgz023. doi: 10.1210/clinem/dgz023. [Epub ahead of print]

PMID:
31513250
5.

Mesoporous bioactive glasses for the combined application of osteosarcoma treatment and bone regeneration.

Ravanbakhsh M, Labbaf S, Karimzadeh F, Pinna A, Houreh AB, Nasr-Esfahani MH.

Mater Sci Eng C Mater Biol Appl. 2019 Nov;104:109994. doi: 10.1016/j.msec.2019.109994. Epub 2019 Jul 19.

PMID:
31500021
6.

In vivo functionalization of diatom biosilica with sodium alendronate as osteoactive material.

Cicco SR, Vona D, Leone G, De Giglio E, Bonifacio MA, Cometa S, Fiore S, Palumbo F, Ragni R, Farinola GM.

Mater Sci Eng C Mater Biol Appl. 2019 Nov;104:109897. doi: 10.1016/j.msec.2019.109897. Epub 2019 Jun 16.

PMID:
31500019
8.

Bruck syndrome 2 variant lacking congenital contractures and involving a novel compound heterozygous PLOD2 mutation.

Mumm S, Gottesman GS, Wenkert D, Campeau PM, Nenninger A, Huskey M, Bijanki VN, Veis DJ, Barnes AM, Marini JC, Stolina M, Zhang F, McAlister WH, Whyte MP.

Bone. 2019 Aug 28:115047. doi: 10.1016/j.bone.2019.115047. [Epub ahead of print]

PMID:
31472299
9.

miR-101-3p/Rap1b signal pathway plays a key role in osteoclast differentiation after treatment with bisphosphonates.

Li J, Li Y, Wang S, Che H, Wu J, Ren Y.

BMB Rep. 2019 Aug 29. pii: 4576. [Epub ahead of print]

10.

Melatonin prevents bone destruction in mice with retinoic acid-induced osteoporosis.

Wang X, Liang T, Zhu Y, Qiu J, Qiu X, Lian C, Gao B, Peng Y, Liang A, Zhou H, Yang X, Liao Z, Li Y, Xu C, Su P, Huang D.

Mol Med. 2019 Aug 28;25(1):43. doi: 10.1186/s10020-019-0107-0.

11.

Does Routine Anti-Osteoporosis Medication Lower the Risk of Fractures in Male Subjects? An Updated Systematic Review With Meta-Analysis of Clinical Trials.

Zeng LF, Pan BQ, Liang GH, Luo MH, Cao Y, Guo D, Chen HY, Pan JK, Huang HT, Liu Q, Guan ZT, Han YH, Zhao D, Zhao JL, Hou SR, Wu M, Lin JT, Li JH, Liang WX, Ou AH, Wang Q, Yang WY, Liu J.

Front Pharmacol. 2019 Aug 9;10:882. doi: 10.3389/fphar.2019.00882. eCollection 2019.

12.

"Holidays" for osteoporosis drugs: A case-based approach.

Anagnostis P, Paschou SA, Kenanidis E, Lambrinoudaki I, Potoupnis M, Tsiridis E, Goulis DG.

Case Rep Womens Health. 2019 Jun 8;23:e00127. doi: 10.1016/j.crwh.2019.e00127. eCollection 2019 Jul.

13.

Review: Long-term alendronate or zoledronic acid reduces fractures in postmenopausal women with osteoporosis.

Bauer DC.

Ann Intern Med. 2019 Aug 20;171(4):JC22. doi: 10.7326/ACPJ201908200-022. No abstract available.

PMID:
31426065
14.

Fracture and Bone Mineral Density Response by Baseline Risk in Patients Treated With Abaloparatide Followed by Alendronate: Results From the Phase 3 ACTIVExtend Trial.

Leder BZ, Zapalowski C, Hu MY, Hattersley G, Lane NE, Singer AJ, Dore RK.

J Bone Miner Res. 2019 Aug 14. doi: 10.1002/jbmr.3848. [Epub ahead of print]

PMID:
31411768
15.

Reduced Bone Loss Is Associated With Reduced Mortality Risk in Subjects Exposed to Nitrogen Bisphosphonates: A Mediation Analysis.

Bliuc D, Tran T, van Geel T, Adachi JD, Berger C, van den Bergh J, Eisman JA, Geusens P, Goltzman D, Hanley DA, Josse R, Kaiser S, Kovacs CS, Langsetmo L, Prior JC, Nguyen TV, Center JR; CaMOS Research Group.

J Bone Miner Res. 2019 Aug 12. doi: 10.1002/jbmr.3816. [Epub ahead of print]

PMID:
31402509
16.

Resistive exercise in astronauts on prolonged spaceflights provides partial protection against spaceflight-induced bone loss.

Sibonga J, Matsumoto T, Jones J, Shapiro J, Lang T, Shackelford L, Smith SM, Young M, Keyak J, Kohri K, Ohshima H, Spector E, LeBlanc A.

Bone. 2019 Aug 7;128:112037. doi: 10.1016/j.bone.2019.07.013. [Epub ahead of print]

PMID:
31400472
19.

Effects of pentoxifylline and alendronate on fracture healing in ovariectomy-induced osteoporosis in rats.

Vashghani Farahani MM, Masteri Farahani R, Abdollahifar MA, Ghatresaman M, Ghoreishi SK, Hajihossainlou B, Chien S, Mostafavinia A, Rezaei F, Bayat M.

Vet Res Forum. 2019 Spring;10(2):93-100. doi: 10.30466/vrf.2018.82732.2089. Epub 2019 Jun 15.

20.

Elimination of intravenous alendronate by hemodialysis: A kinetic study.

Iseri K, Watanabe M, Lee XP, Yamada M, Ryu K, Iyoda M, Uchida N, Sato K, Shibata T.

Hemodial Int. 2019 Jul 22. doi: 10.1111/hdi.12773. [Epub ahead of print]

PMID:
31328884

Supplemental Content

Loading ...
Support Center